SSWM
MDCO

Sheets Smith Wealth Management’s Medicines Co MDCO Stock Holding History

Sheets Smith Wealth Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-13,503
Closed -$415K – 259
2013
Q2 		$415K Buy
+13,503
New +$452K 0.14% 181

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sheets Smith Wealth Management's MDCO Position: Q3 2013 in Review

Sheets Smith Wealth Management sold out of Medicines Co (MDCO) in Q3 2013, closing a stake of 13,503 shares — an estimated $415K sold.

Sheets Smith Wealth Management first reported a position in MDCO in Q2 2013 and held it in 1 quarter. The position peaked at $415K in Q2 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q3 2013.

  • Sheets Smith Wealth Management reported no remaining Medicines Co position as of Q3 2013 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 13,503 Medicines Co shares in Q3 2013, an estimated $415K.
  • Sheets Smith Wealth Management first reported a position in Medicines Co in Q2 2013 and held it in 1 quarter.
  • Sheets Smith Wealth Management's Medicines Co position peaked at $415K in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q3 2013.

Based on Sheets Smith Wealth Management's 13F filing for Q3 2013, filed 26 Nov 2013.